Interestingly, decreased CD81 expression has been associated with increased metastatic capacity in liver cancer and bladder cancers [19,20], while the knockdown of CD81 has been shown to decrease cell motility and metastasis in melanoma and breast cancer [21,22,23]. Here, CD81 is linked to breast carcinoma.